Fecal microbiota spores, live (Seres)

N/A

Report date: 2023/04/27 10:28:15
First In Class

Base Information

Drug NameFecal microbiota spores, live (Seres)
Drug Alias NameEncapsulated fecal-derived bacterial sporesfecal microbiota spores, live-brpkVowstSER-109
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacementsMicrobiome modulators
TargetsNot applicable
Therapy Area/IndicationsClostridium Infections
Global Approved IndicationsClostridium Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2023/04/26
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSeres Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSociété des Produits Nestlé SANestlé Health ScienceSeres Therapeutics Inc +[4] 
Inactive CompaniesN/A
Active IndicationsClostridium Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A